HALO vs Viz Subdural+
AI Verdict
Choose HALO if…
Choose HALO if your primary need is rapid, AI-powered detection and triage for acute stroke patients, specifically focusing on large vessel occlusions and intracerebral hemorrhages. This tool is ideal for accelerating time-sensitive interventions by providing automated notifications and facilitating the evaluation of brain vasculature on CT angiograms.
View HALO →Choose Viz Subdural+ if…
Choose Viz Subdural+ if your focus is on comprehensive, automated detection, labeling, and quantification of subdural hemorrhages (acute and chronic) on non-contrast CT scans. This tool is particularly well-suited for streamlining the diagnostic workflow and care coordination specifically for subdural conditions, offering detailed measurements like volume and midline shift.
View Viz Subdural+ →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | HALO | Viz Subdural+ |
|---|---|---|
| Pricing | Not disclosed | Subscription model |
| Deployment | Cloud-based (Google Cloud Platform) | Cloud-native platform, available as part of the Viz.ai One platform. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz Subdural+Viz Subdural+ (Tool B) offers a more comprehensive and integrated user experience through its Viz.ai One platform, which emphasizes streamlined workflows, HIPAA-compliant communication, and accessibility across mobile and desktop devices. HALO (Tool A) provides essential features like automated notifications and remote image review via a web viewer, but Viz.ai's broader platform approach and focus on care coordination suggest a more unified and potentially intuitive user journey.
Clinical Value
TieBoth tools offer significant clinical value in their respective domains. HALO (Tool A) provides comprehensive detection and quantification for large vessel occlusions (LVO) and intracerebral hemorrhages (ICH) in acute stroke, crucial for time-sensitive interventions. Viz Subdural+ (Tool B) offers highly precise and automated detection, labeling, and quantification of subdural hemorrhages, a unique capability. Both have strong clinical validation for their specific indications, making it difficult to declare a definitive winner in overall clinical value without specific use case prioritization.
Pricing & Value
Viz Subdural+Viz Subdural+ (Tool B) offers slightly more transparency regarding its pricing model, which is a subscription for enterprise use, and there is public information about potential CMS reimbursement mechanisms for Viz.ai's stroke-related AI tools. HALO (Tool A) does not disclose any pricing information, making it impossible to assess its value proposition without direct vendor contact.
Enterprise Readiness
Viz Subdural+Viz Subdural+ (Tool B) demonstrates superior enterprise readiness as it is part of the comprehensive Viz.ai One platform, which is deployed in over 1,800 hospitals and supports more than 50 FDA-cleared algorithms across multiple service lines. This platform offers unified care coordination, extensive EHR and PACS integrations, and capabilities for health systems to build custom AI care pathways, indicating a highly scalable and integrated solution for complex healthcare environments.
Innovation
Viz Subdural+Viz Subdural+ (Tool B) demonstrates higher innovation, particularly with its 'first and only' comprehensive solution for quantifying subdural hemorrhages, automating a traditionally manual and time-consuming process. Furthermore, Viz.ai's broader Viz.ai One platform, which allows health systems to build and scale their own AI care pathways with Viz Agent Studio, represents a significant platform-level innovation that empowers customers and extends beyond specific disease detection.
Support & Docs
Viz Subdural+Viz Subdural+ (Tool B) appears to offer more comprehensive and publicly accessible support and documentation, including 24/7 urgent phone support, email, in-app support, a detailed Help Center/Knowledge Base with tutorials, and dedicated customer success teams. While HALO (Tool A) also provides dedicated support and training, there is an indication of limited publicly available technical documentation.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | HALO | Viz Subdural+ |
|---|---|---|
| Name | HALO | Viz Subdural+ |
| Company | Nico.Lab B.V. | Viz.ai |
| Description | AI-powered, cloud-based clinical support tool for the rapid detection of large vessel occlusions and intracerebral hemorrhage in acute stroke patients, providing timely notifications to medical specialists. | AI-powered tool by Viz.ai that automates the detection, labeling, and quantification of subdural hemorrhages on non-contrast CT scans, streamlining diagnosis and care coordination for neurovascular conditions. |
| Key Detections | Large Vessel Occlusion (LVO) detection, Intracerebral Hemorrhage (ICH) detection and volume quantification | Acute and chronic subdural hemorrhages (auto-detection, labeling, quantification of volume, thickness, and midline shift) |
| Specialties | Emergency Medicine, Neurology, Radiology | Neurology, Neurosurgery, Radiology |
| Integration | DICOM / PACS integration | Integration into the Viz.ai One platform |
Videos
Demos, reviews, and walkthroughs featuring HALO and Viz Subdural+.